+ A
A -
Tribune News Network
Doha
Sidra Medicine, a Qatar Foundation entity, has appointed Dr Barbro Fridén as its Chief Executive Officer.
Dr Fridén has extensive experience in both the public and private healthcare sectors in Sweden and the Middle East.
Prior to joining Sidra Medicine, Dr Fridén was the CEO of Sheikh Khalifa Medical City in Ajman and before that, the CEO of Sahlgrenska University Hospital, Scandinavia’s largest teaching hospital.
Dr Fridén was previously the Hospital Director of the Children’s Hospital at Karolinska University Hospital in Sweden.
Mohammed Khalid Al Mana, managing director and member of the Board of Governors at Sidra Medicine, said: “We are delighted to have Dr Barbro Fridén join us at Sidra Medicine. Her leadership experience in obstetrics and gynaecology and experience in having led women’s and children’s hospitals in Sweden, will be a tremendous asset to our patient care model as we embark on strengthening and expanding our services in Qatar. We look forward to Dr Fridén’s stewardship over the next chapter of our journey towards achieving our overall vision of becoming a beacon of learning, discovery and exceptional care.”
Dr Fridén said: “I am excited to be joining Sidra Medicine during this dynamic phase as the healthcare organisation is poised for new opportunities for growth. Together with our diverse multidisciplinary teams, I look forward to building on Sidra Medicine’s legacy of providing quality care and a personalized patient experience with excellent medical outcomes built on a strong research foundation of precision medicine.”
Dr Fridén is well recognised within her field having won ‘Leader of the Year’, a national award in Sweden in 2015, as well as ‘Influencer of the Year’ in 2014, a life science business national award.
Dr Fridén sits on the board on a variety of government and commercial boards related to healthcare including a leading medtech company and Sophiahemmet, a non-profit healthcare provider under royal stewardship that conducts education, healthcare and research.
Dr Fridén received her medical degree from Ume? University in Sweden, specialising in obstetrics and gynzecology with a subspecialty in reproductive medicine and IVF. She was also a visiting research fellow in reproductive medicine at the University of California. She holds a PhD in Medicine from Gothenburg University.
Doha
Sidra Medicine, a Qatar Foundation entity, has appointed Dr Barbro Fridén as its Chief Executive Officer.
Dr Fridén has extensive experience in both the public and private healthcare sectors in Sweden and the Middle East.
Prior to joining Sidra Medicine, Dr Fridén was the CEO of Sheikh Khalifa Medical City in Ajman and before that, the CEO of Sahlgrenska University Hospital, Scandinavia’s largest teaching hospital.
Dr Fridén was previously the Hospital Director of the Children’s Hospital at Karolinska University Hospital in Sweden.
Mohammed Khalid Al Mana, managing director and member of the Board of Governors at Sidra Medicine, said: “We are delighted to have Dr Barbro Fridén join us at Sidra Medicine. Her leadership experience in obstetrics and gynaecology and experience in having led women’s and children’s hospitals in Sweden, will be a tremendous asset to our patient care model as we embark on strengthening and expanding our services in Qatar. We look forward to Dr Fridén’s stewardship over the next chapter of our journey towards achieving our overall vision of becoming a beacon of learning, discovery and exceptional care.”
Dr Fridén said: “I am excited to be joining Sidra Medicine during this dynamic phase as the healthcare organisation is poised for new opportunities for growth. Together with our diverse multidisciplinary teams, I look forward to building on Sidra Medicine’s legacy of providing quality care and a personalized patient experience with excellent medical outcomes built on a strong research foundation of precision medicine.”
Dr Fridén is well recognised within her field having won ‘Leader of the Year’, a national award in Sweden in 2015, as well as ‘Influencer of the Year’ in 2014, a life science business national award.
Dr Fridén sits on the board on a variety of government and commercial boards related to healthcare including a leading medtech company and Sophiahemmet, a non-profit healthcare provider under royal stewardship that conducts education, healthcare and research.
Dr Fridén received her medical degree from Ume? University in Sweden, specialising in obstetrics and gynzecology with a subspecialty in reproductive medicine and IVF. She was also a visiting research fellow in reproductive medicine at the University of California. She holds a PhD in Medicine from Gothenburg University.
